Neumora Therapeutics (NMRA) Earnings Date & Reports

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NMRA is expected to report earnings to fall 10.00% to -27 cents per share on August 12

Neumora Therapeutics NMRA Stock Earnings Reports

Q2'26

Est.

$-0.27

Q1'26

Est.

$-0.30

Q4'25

Beat

by $0.12

Q3'25

Beat

by $0.10

Q2'25

Beat

by $0.12

The last earnings report on May 07 showed earnings per share of -30 cents, meeting the estimate of -30 cents. With 916.45K shares outstanding, the current market capitalization sits at 286.26M.

View a ticker or compare two or three

Compare

NMRA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NMRA